• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定B2受体G蛋白解偶联状态的缓激肽拮抗剂在大鼠子宫肌层细胞中作为反向激动剂发挥作用。

Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells.

作者信息

Leeb-Lundberg L M, Mathis S A, Herzig M C

机构信息

Department of Biochemistry, University of Texas Health Science Center, San Antonio 78284-7760.

出版信息

J Biol Chem. 1994 Oct 21;269(42):25970-3.

PMID:7929307
Abstract

Several B2 bradykinin (BK) receptor-specific antagonists including HOE140, NPC17731, and NPC567 exhibited negative intrinsic activity, which was observed as a decrease in basal phosphoinositide hydrolysis in primary cultures of rat myometrial cells, and this response was opposite to that elicited by the agonist BK. The order of potency of the antagonists in attenuating basal activity was essentially the same as that in competing both [3H]BK and [3H]NPC17731 for binding to B2 receptors on both intact rat myometrial cells and bovine myometrial membranes. We previously proposed a three-state model for the binding of agonists to G-protein-coupled B2 receptors in bovine myometrial membranes (Leeb-Lundberg, L. M. F. and Mathis, S. A. (1990) J. Biol. Chem. 265, 9621-9627). This model was based on the ability of BK to promote the sequential formation of three receptor binding states where formation of the third, equilibrium state was blocked by Gpp(NH)p (guanyl-5'-yl imidodiphosphate) identifying it as the G-protein-coupled state of the receptor. Here, we show that, in contrast to BK, these antagonists bound preferentially to a G-protein-uncoupled state of the receptor. These results indicate that B2 receptor antagonists that stabilize a G-protein-uncoupled state of the receptor act as inverse agonists. Furthermore, these results provide strong evidence that endogenous G-protein-coupled receptors exhibit spontaneous activity in their natural environment in the absence of agonist occupancy.

摘要

几种B2缓激肽(BK)受体特异性拮抗剂,包括HOE140、NPC17731和NPC567,表现出负性内在活性,这在大鼠子宫肌层细胞原代培养物中表现为基础磷酸肌醇水解的降低,且这种反应与激动剂BK引发的反应相反。拮抗剂减弱基础活性的效力顺序与在完整大鼠子宫肌层细胞和牛子宫肌层膜上竞争[3H]BK和[3H]NPC17731与B2受体结合的效力顺序基本相同。我们之前提出了一个激动剂与牛子宫肌层膜中G蛋白偶联B2受体结合的三态模型(Leeb-Lundberg,L.M.F.和Mathis,S.A.(1990)J.Biol.Chem.265,9621 - 9627)。该模型基于BK促进三种受体结合状态顺序形成的能力,其中第三种平衡状态的形成被Gpp(NH)p(鸟苷 - 5'-基亚氨二磷酸)阻断,这将其确定为受体的G蛋白偶联状态。在此,我们表明,与BK相反,这些拮抗剂优先结合受体的G蛋白非偶联状态。这些结果表明,稳定受体G蛋白非偶联状态的B2受体拮抗剂作为反向激动剂起作用。此外,这些结果提供了有力证据,表明内源性G蛋白偶联受体在没有激动剂占据的自然环境中表现出自发活性。

相似文献

1
Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells.稳定B2受体G蛋白解偶联状态的缓激肽拮抗剂在大鼠子宫肌层细胞中作为反向激动剂发挥作用。
J Biol Chem. 1994 Oct 21;269(42):25970-3.
2
The agonist binding site on the bovine bradykinin B2 receptor is adjacent to a sulfhydryl and is differentiated from the antagonist binding site by chemical cross-linking.牛缓激肽B2受体上的激动剂结合位点与一个巯基相邻,并且通过化学交联与拮抗剂结合位点相区分。
J Biol Chem. 1995 Sep 1;270(35):20591-8. doi: 10.1074/jbc.270.35.20591.
3
Bradykinin recognizes different molecular forms of the B2 kinin receptor in the presence and absence of guanine nucleotides.在存在和不存在鸟嘌呤核苷酸的情况下,缓激肽可识别B2激肽受体的不同分子形式。
Biochem J. 1991 May 15;276 ( Pt 1)(Pt 1):141-7. doi: 10.1042/bj2760141.
4
Bradykinin binding to B2 kinin receptors and stimulation of phosphoinositide turnover and arachidonic acid release in primary cultures of cells from late pregnant rat myometrium.缓激肽与晚期妊娠大鼠子宫肌层细胞原代培养物中的B2激肽受体结合,并刺激磷酸肌醇代谢和花生四烯酸释放。
Can J Physiol Pharmacol. 1992 Oct;70(10):1360-71. doi: 10.1139/y92-191.
5
Spontaneous human B2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. Effect of basal desensitization.人类自发的B2缓激肽受体活性决定了部分激动剂作为激动剂或反向激动剂的作用。基础脱敏的影响。
J Biol Chem. 1999 Oct 15;274(42):29603-6. doi: 10.1074/jbc.274.42.29603.
6
Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells.缓激肽在DDT1 MF-2平滑肌细胞的小窝中隔离B2缓激肽受体以及与受体偶联的Gα亚基Gαq和Gαi。
J Biol Chem. 1997 Jul 11;272(28):17858-66. doi: 10.1074/jbc.272.28.17858.
7
A single position in the third transmembrane domains of the human B1 and B2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype-selective ligands.人类B1和B2缓激肽受体第三个跨膜结构域中的一个单一位置与亚型选择性配体的C端残基相邻且对其具有区分作用。
J Biol Chem. 1998 May 15;273(20):12210-8. doi: 10.1074/jbc.273.20.12210.
8
Characterization of bradykinin receptors in human lung fibroblasts using the binding of 3[H][Des-Arg10,Leu9]kallidin and [3H]NPC17731.利用3[H][去-精氨酸10,亮氨酸9]缓激肽和[3H]NPC17731的结合对人肺成纤维细胞中的缓激肽受体进行表征。
Life Sci. 1998;62(25):2303-14. doi: 10.1016/s0024-3205(98)00211-2.
9
Characterization of bradykinin receptors in guinea pig gall bladder.豚鼠胆囊中缓激肽受体的特性研究
J Pharmacol Exp Ther. 1993 Sep;266(3):1291-9.
10
Guanosine nucleotides regulate B2 kinin receptor affinity of agonists but not of antagonists: discussion of a model proposing receptor precoupling to G protein.鸟苷酸调节激动剂而非拮抗剂对B2激肽受体的亲和力:对受体与G蛋白预偶联模型的讨论。
Biol Chem. 2000 Apr;381(4):295-302. doi: 10.1515/BC.2000.038.

引用本文的文献

1
Molecular mechanisms of inverse agonism via κ-opioid receptor-G protein complexes.通过κ-阿片受体-G蛋白复合物产生反向激动作用的分子机制。
Nat Chem Biol. 2025 Jan 7. doi: 10.1038/s41589-024-01812-0.
2
Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.采用G蛋白偶联受体激动作用和信号传导的新兴模式来解决哮喘中的气道平滑肌病理生物学问题。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Aug;378(2):149-69. doi: 10.1007/s00210-008-0263-1. Epub 2008 Feb 16.
3
From the H(2) receptor gene to reclassification of the H(2) receptor antagonists.
从 H2 受体基因到 H2 受体拮抗剂的再分类。
Inflammopharmacology. 1998;6(2):179-92. doi: 10.1007/s10787-998-0033-1.
4
Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies.天然小鼠缓激肽B2受体的比较性拮抗剂药理学:放射性配体结合及平滑肌收缩性研究
Br J Pharmacol. 2007 Feb;150(3):313-20. doi: 10.1038/sj.bjp.0706995. Epub 2006 Dec 18.
5
Genetic variations in human G protein-coupled receptors: implications for drug therapy.人类G蛋白偶联受体的基因变异:对药物治疗的影响。
AAPS PharmSci. 2001;3(3):E22. doi: 10.1208/ps030322.
6
Bradykinin increases Na(+)-K(+) pump activity in cultured guinea-pig tracheal smooth muscle cells.缓激肽可增加培养的豚鼠气管平滑肌细胞中的钠钾泵活性。
Br J Pharmacol. 2001 Aug;133(8):1339-45. doi: 10.1038/sj.bjp.0704198.
7
In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.在多种肿瘤细胞系中,肽类缓激肽B(2)受体拮抗剂Hoe 140(依卡替班)可能作为促有丝分裂激动剂发挥作用。
Br J Pharmacol. 2000 Dec;131(8):1553-60. doi: 10.1038/sj.bjp.0703764.
8
G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.μ-阿片受体(OP3)的G蛋白偶联:基础信号活性升高。
Biochem J. 2000 Jun 15;348 Pt 3(Pt 3):531-7.
9
Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.G蛋白偶联受体的反向激动作用:(病理)生理学相关性及对药物发现的影响
Br J Pharmacol. 2000 May;130(1):1-12. doi: 10.1038/sj.bjp.0703311.
10
Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.β-肾上腺素能受体拮抗剂在大鼠心肌中的反向激动剂活性。
Br J Pharmacol. 1999 Jun;127(4):895-902. doi: 10.1038/sj.bjp.0702616.